51
|
Coussy F, Le Scodan R, Guinebretiere JM, Langer A, Lerebours F. Breast Mass With Intense 99mTc–Diphosphonate Uptake Revealing Primary Breast Osteosarcoma. J Clin Oncol 2011; 29:e428-30. [DOI: 10.1200/jco.2010.33.6719] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
52
|
Lee S, Lee MR, Lee SJ, Ahn HK, Yi J, Yi SY, Seo SW, Sung KS, Park JO, Lee J. Extraosseous osteosarcoma: single institutional experience in Korea. Asia Pac J Clin Oncol 2010; 6:126-9. [PMID: 20565425 DOI: 10.1111/j.1743-7563.2010.01278.x] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
AIM Extraosseous osteosarcoma (EOO) is a rare soft tissue form of osteosarcoma without involvement of the skeletal system. Due to the rarity of disease, its clinical features and optimal treatment are yet to be defined. METHODS Between 1 January 1999 and 30 June 2008 ten patients were pathologically confirmed with extra-skeletal osteosarcoma. A retrospective analysis of the ten patients was performed. RESULTS The anatomical distribution of the osteosarcomas was as follows: lower extremities (n = 3), upper extremities (n = 2), breast (n = 2), lung (n = 1), cheek (n = 1) and retroperitoneum (n = 1). Nine patients initially underwent resection of the primary mass. One patient, who received six cycles of adjuvant doxorubicin and cisplatin chemotherapy was alive in remission at 42.6 months. One patient with postoperative radiotherapy after curative surgery was alive in remission at 6.2 months. However, all three patients who received curative resection but no postoperative radiotherapy or chemotherapy died of the disease at 10.7, 11.1 and 15.6 months after surgery. The median time to failure was only 4.4 months (95% CI, 0.6, 8.2 months) and the median survival time of all patients was only 11.1 months (95% CI, 5.6, 16.6 months). At the time of analysis, seven patients were dead and all died of the disease recurrence. CONCLUSION EOO should be treated as a soft tissue sarcoma with aggressive behavior and multimodality treatment should be actively sought to improve treatment outcome. The impact of adjuvant chemotherapy on survival of EOO needs further investigation.
Collapse
Affiliation(s)
- Soohyeon Lee
- Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
| | | | | | | | | | | | | | | | | | | |
Collapse
|
53
|
Abstract
Soft tissue sarcomas (STS) with complex genomic profiles (50% of all STS) are predominantly composed of spindle cell/pleomorphic sarcomas, including leiomyosarcoma, myxofibrosarcoma, pleomorphic liposarcoma, pleomorphic rhabdomyosarcoma, malignant peripheral nerve sheath tumor, angiosarcoma, extraskeletal osteosarcoma, and spindle cell/pleomorphic unclassified sarcoma (previously called spindle cell/pleomorphic malignant fibrous histiocytoma). These neoplasms show, characteristically, gains and losses of numerous chromosomes or chromosome regions, as well as amplifications. Many of them share recurrent aberrations (e.g., gain of 5p13-p15) that seem to play a significant role in tumor progression and/or metastatic dissemination. In this paper, we review the cytogenetic, molecular genetic, and clinicopathologic characteristics of the most common STS displaying complex genomic profiles. Features of diagnostic or prognostic relevance will be discussed when needed.
Collapse
Affiliation(s)
- Louis Guillou
- University Institute of Pathology, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Rue du Bugnon 25, Lausanne, Switzerland.
| | | |
Collapse
|
54
|
Wegner RE, McGrath KM, Luketich JD, Friedland DM. Extraosseous osteosarcoma of the esophagus: a case report. Sarcoma 2010; 2010:907127. [PMID: 20224681 PMCID: PMC2833302 DOI: 10.1155/2010/907127] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/10/2009] [Accepted: 01/14/2010] [Indexed: 12/02/2022] Open
Abstract
Extraosseous osteosarcoma (EOO) is a malignant mesenchymal neoplasm that is located in the soft tissues without direct attachment to the skeletal system and that produces osteoid, bone, or chondroid material. EOO is an extremely rare disease, accounting for only 1% of soft tissue sarcomas, and typically presents in either an extremity or the retroperitoneum. This paper presents the case of a 45-year-old Caucasian male with extraosseous osteosarcoma of the esophagus.
Collapse
Affiliation(s)
- Rodney E. Wegner
- UPMC Shadyside Hospital, Department of Radiation Oncology, University of Pittsburgh School of Medicine, 5230 Centre Avenue, Pittsburgh, PA 15232, USA
| | - Kevin M. McGrath
- Division of Gastroenterology, Hepatology, and Nutrition, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA
| | - James D. Luketich
- Heart, Lung, and Esophageal Surgery Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA
| | - David M. Friedland
- Department of Medical Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA
| |
Collapse
|
55
|
Extraskeletal osteosarcoma of the thigh: an autopsy case report. Sarcoma 2009; 2009:186565. [PMID: 19753130 PMCID: PMC2694310 DOI: 10.1155/2009/186565] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2008] [Revised: 01/08/2009] [Accepted: 04/13/2009] [Indexed: 11/18/2022] Open
Abstract
We report a case of extraskeletal osteosarcoma (ESOS) and autopsy findings. A 35-year-old man presented with an ossified tumor in the right thigh and lung metastasis. The lung tumors continued to develop despite multiagent chemotherapy and caused death within 8 months. Autopsy revealed many secondary lesions in the lungs, especially in the left lung. Histopathologically, the primary tumor and one of the secondary tumors showed proliferation of spindle-shaped tumor cells focally forming lace-like osteoid material. Therefore, we made a definite diagnosis of ESOS.
Collapse
|
56
|
Alonge TO, Obamuyide HA, Ogun GO. Extraosseous osteosarcoma in Ibadan: case series over a 20-year period. Rare Tumors 2009; 1:e3. [PMID: 21139897 PMCID: PMC2994438 DOI: 10.4081/rt.2009.e3] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2009] [Accepted: 05/05/2009] [Indexed: 11/22/2022] Open
Abstract
Extraosseous osteosarcoma (EOO) is a rare form of sarcoma. There have been few reports of cases and outcome from an African population.Out of 112 cases of sarcomas seen at the UCH, Ibadan between 1986-2005, 5 were EOO. All presented late on account of initial excision without histology and outcomes were poor. EOO occurs in the black population of Sub-Saharan Africa. The outlook for these patients is still bleak.
Collapse
Affiliation(s)
- Temitope O Alonge
- Consultant Orthopedic Surgeon/Senior Lecturer, Department of Orthopedics and Trauma, University College Hospital, and College of Medicine, University of Ibadan, Ibadan, Nigeria
| | | | | |
Collapse
|
57
|
Zhang HJ, Yang JJ, Lu JP, Sheng J, Yuan M, Jiang X, Li YX, Gupta S. Retroperitoneal Extraskeletal Osteosarcoma: Imaging Findings and Transarterial Chemoembolization. Cardiovasc Intervent Radiol 2009; 33:430-4. [DOI: 10.1007/s00270-009-9575-x] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/06/2009] [Revised: 03/18/2009] [Accepted: 03/23/2009] [Indexed: 11/28/2022]
|
58
|
|
59
|
Abstract
Pure osteosarcomas, in which this tumor is not the mesenchymal component of a biphasic tumor, are only rarely encountered in the ovary. Herein, we report a case of a pure ovarian osteoarcoma and review all previously reported cases of ovarian involvement by osteosarcoma in the English literature. The latter includes (with the present case) 6 cases of pure osteosarcoma (Group A), 5 cases of osteosarcoma arising from a teratoma (Group B), and 2 cases of osteosarcomas of osseous origin (humerus and maxilla) metastatic to the ovary (Group C). The average ages of the Groups A, B, and C patients were 52.6, 52, and 37.5 years, respectively. The average tumor sizes in these groups were 13.46, 13.82, and 16 cm, respectively. There was no statististically significant difference between the Group A and B patients with respect to tumor size (P = 0.94) or age (P = 0.96) (t test). Eight of the 11 patients in groups A and B were FIGO stage 3 or 4 at presentation. Five (83%) of the 6 group A patients and 2 (40%) of the 5 group B patients died of their disease an average of 4.8 and 3.5 months after initial evaluations respectively. However, the 2 patients who presented with stage 1 disease (and with follow-up information) have shown no evidence of tumor recurrence at an average of 26 months' follow-up. It is concluded that ovarian osteosarcomas are rare malignancies that are frequently associated with teratomas but may be seen in pure form. Unlike osseous osteosarcoma whose peak age of incidence is in the second decade, ovarian osteosarcomas occur at an older age group. Most patients have advanced stage disease at presentation. Ovarian osteosarcomas have a high (>60%) case fatality rate; analysis of the reported cases suggests that the latter is attributable to the advanced stage at which most patients present, as there are no reported cases of patients with stage 1 disease whose diseases have recurred after surgical resection or who have died of their disease.
Collapse
Affiliation(s)
- Oluwole Fadare
- Department of Pathology, Yale-New Haven Hospital and Yale University School of Medicine, New Haven, Connecticut, USA.
| | | | | | | |
Collapse
|
60
|
Wong C, Wright C, Colclough A, Marsh S. Case report: Metaplastic carcinoma presenting as a breast abscess. INTERNATIONAL SEMINARS IN SURGICAL ONCOLOGY 2006; 3:23. [PMID: 16948857 PMCID: PMC1564404 DOI: 10.1186/1477-7800-3-23] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/10/2006] [Accepted: 09/02/2006] [Indexed: 11/23/2022]
Abstract
Metaplastic breast carcinoma (MBC) is a rare neoplasm containing a mixture of epithelial and mesenchymal elements. The epithelial component is usually ductal carcinoma but may include other variants of breast carcinomas including squamous carcinoma and osteogenic sarcoma. There is a relative paucity of data regarding such tumours. Metaplastic carcinoma carries a prognosis not dissimilar to that of comparable ductal carcinoma. This is the case of a 57 year old patient with MBC presenting with a breast abscess. A thorough literature search has not revealed any previous reports of MBC presenting as a breast abscess.
Collapse
Affiliation(s)
- Corrine Wong
- SHO in Surgery, Essex Rivers Healthcare NHS Trust, Department of Surgery, Colchester General Hospital, Turner Road, Colchester, Essex, CO4 5JL, UK
| | - Chris Wright
- SHO in Surgery, Department of Surgery, Essex Rivers Healthcare NHS Trust, Colchester General Hospital, Turner Road, Colchester, Essex, CO4 5JL, UK
| | - Angela Colclough
- Consultant Pathologist, Department of Histopathology, Essex Rivers Healthcare NHS Trust, Colchester General Hospital, Turner Road, Colchester, Essex, CO4 5JL, UK
| | - Simon Marsh
- Consultant Surgeon, Department of Surgery, Essex Rivers Healthcare NHS Trust, Colchester General Hospital, Turner Road, Colchester, Essex, CO4 5JL, UK
| |
Collapse
|
61
|
Carrle D, Bielack SS. Current strategies of chemotherapy in osteosarcoma. INTERNATIONAL ORTHOPAEDICS 2006; 30:445-51. [PMID: 16896870 PMCID: PMC3172747 DOI: 10.1007/s00264-006-0192-x] [Citation(s) in RCA: 146] [Impact Index Per Article: 7.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/11/2006] [Accepted: 05/12/2006] [Indexed: 11/24/2022]
Abstract
Osteosarcoma, the most common type of primary malignant tumour that develops in bone, can be classified into several different sub-types. While the majority of osteosarcomas are highly malignant, there are some low-grade variants. Since the introduction of chemotherapy into the multi-modal treatment regimen of high-grade osteosarcoma, its prognosis has impressively improved, with long-term survival being achieved in two-thirds of all patients. This review summarises current chemotherapeutic treatment strategies in classical osteosarcoma and also addresses the indication for chemotherapy in more unusual types and variants. It emphasises the need for treatment in specialised centres and within prospective, multi-institutional trials, amongst which EURAMOS1 and EURO-B.O.S.S are currently active in many European countries.
Collapse
Affiliation(s)
- Dorothe Carrle
- Pediatrics 5 (Oncology, Haematology, Immunology), Klinikum Stuttgart, Olgahospital, Stuttgart, Germany
| | - Stefan S. Bielack
- Pediatrics 5 (Oncology, Haematology, Immunology), Klinikum Stuttgart, Olgahospital, Stuttgart, Germany
- Department of Paediatric Hematology and Oncology, University Children’s Hospital Muenster, Muenster, Germany
- Pädiatrie 5 (Onkologie, Hämatologie, Immunologie), Olgahospital-Pädiatrisches Zentrum der Landeshauptstadt Stuttgart, Klinik für Kinder- und Jugendmedizin, Bismarckstr. 8, 70176 Stuttgart, Germany
| |
Collapse
|
62
|
Olgyai G, Horváth V, Banga P, Kocsis J, Buza N, Oláh A. Extraskeletal osteosarcoma located to the gallbladder. HPB (Oxford) 2006; 8:65-6. [PMID: 18333242 PMCID: PMC2131365 DOI: 10.1080/13651820600573204] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
Extraskeletal osteosarcoma is a rare malignant soft tissue tumour. At open cholecystectomy performed for gallstones, a 61-year-old woman was found to have osseous tissue in the wall of the gallbladder. Histopathological examination of the specimen revealed a focus of extraskeletal osteosarcoma. The patient developed widespread intra-abdominal metastases 5 months after the operation, and died of pulmonary deposits at 9 months. Although osteosarcoma has rarely been reported at other extraskeletal sites, this appears to be the first case of a primary tumour in the gallbladder.
Collapse
Affiliation(s)
- Gábor Olgyai
- Department of Surgery, Petz Aladár Teaching HospitalGyörHungary
| | - Viktor Horváth
- Department of Surgery, Petz Aladár Teaching HospitalGyörHungary
| | - Péter Banga
- Department of Surgery, Petz Aladár Teaching HospitalGyörHungary
| | - József Kocsis
- Department of Pathology, Petz Aladár Teaching HospitalGyörHungary
| | - Natália Buza
- Department of Human and Experimental Tumour Pathology, National Institute of OncologyBudapestHungary
| | - Attila Oláh
- Department of Surgery, Petz Aladár Teaching HospitalGyörHungary
| |
Collapse
|
63
|
Grabellus F, Sheu SY, Schmidt B, Flasshove M, Kuhnen C, Ruchholtz S, Taeger G, Schmid KW. Recurrent high-grade leiomyosarcoma with heterologous osteosarcomatous differentiation. Virchows Arch 2005; 448:85-9. [PMID: 16228225 DOI: 10.1007/s00428-005-0094-0] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/19/2005] [Accepted: 09/09/2005] [Indexed: 10/25/2022]
Abstract
Leiomyosarcomas (LM) of the soft tissue comprise approximately 5-10% of all soft tissue sarcomas. Besides the classic LM, several distinctly uncommon features of the cellular and growth patterns of LM have been described. The term "dedifferentiated LM" has rarely been used in the literature to describe soft tissue LM containing areas of undifferentiated, pleomorphic appearance or detectable heterologous differentiation. We report on a case of high-grade LM with almost entire transition to an osteosarcoma, which was classified as recurrent high-grade LM with heterologous osteosarcomatous differentiation. The identification of areas with osteosarcomatous dedifferentiation in soft tissue sarcomas can be of clinical importance because of a possible change in oncologic treatment strategies.
Collapse
Affiliation(s)
- Florian Grabellus
- Institute of Pathology, University Hospital of Essen, University Duisburg-Essen, Hufelandstrasse 55, 45122 Essen, Germany.
| | | | | | | | | | | | | | | |
Collapse
|
64
|
Goldstein-Jackson SY, Gosheger G, Delling G, Berdel WE, Exner GU, Jundt G, Machatschek JN, Zoubek A, Jürgens H, Bielack SS. Extraskeletal osteosarcoma has a favourable prognosis when treated like conventional osteosarcoma. J Cancer Res Clin Oncol 2005; 131:520-6. [PMID: 15918046 DOI: 10.1007/s00432-005-0687-7] [Citation(s) in RCA: 67] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2004] [Accepted: 03/01/2005] [Indexed: 12/20/2022]
Abstract
PURPOSE The aims of this analysis were to investigate the clinical features of extraskeletal osteosarcoma (ESOS) and examine the outcome after multi-modal therapy. METHODS The co-operative osteosarcoma study-group database was searched for patients with extraskeletal osteosarcoma. Eligible patients were included in a retrospective analysis of patient, tumour and treatment related variables and outcome. As for conventional osteosarcoma, scheduled treatment included surgery and multi-agent chemotherapy. RESULTS Seventeen eligible patients were identified with a median age of 44 years (range, 3-65 years). The thigh was the commonest tumour site. Two patients had a history of previous malignancies and two had primary metastases. Median follow-up was 3.2 years (range: 0.6-7.4 years) and at last follow-up, 11 patients were alive in complete remission, 3 patients were alive with disease and 3 patients had died of their disease. Three-year overall actuarial and event-free survival rates were 77% and 56%, respectively. Patients with macroscopically complete surgical remission had an improved overall survival (P = 0.0004). CONCLUSIONS The patients in this retrospective study had a surprisingly good survival rate. This may be due to the combination of multi-agent chemotherapy with surgery, and we recommend this approach in the treatment of ESOS.
Collapse
Affiliation(s)
- Sing Yu Goldstein-Jackson
- Klinik und Poliklinik für Kinder- und Jugendmedizin, Pädiatrische Hämatologie und Onkologie, Universitätsklinikum Münster, Münster, Albert-Schweitzer-Str. 33, 48149, Germany
| | | | | | | | | | | | | | | | | | | |
Collapse
|
65
|
Vardy J, Joshua AM, Clarke SJ, Yarrow PM, Lin BPC. Small blue cell tumors of the rectum. Case 1. Ewing's sarcoma of the rectum. J Clin Oncol 2005; 23:910-2. [PMID: 15681537 DOI: 10.1200/jco.2005.03.096] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023] Open
Affiliation(s)
- J Vardy
- Department of Medical Oncology, Sydney Cancer Centre, Royal Prince Alfred Hospital, Sydney, Australia
| | | | | | | | | |
Collapse
|
66
|
Affiliation(s)
- Arnold B Alqueza
- College of Medicine, University of Florida, Gainesville, FL, USA
| | | | | | | | | |
Collapse
|